Pharma Marketing News Vol. 13, No. 10: December 2014

Welcome to Volume 13, Issue #10 (DECEMBER 2014) of Pharma Marketing News.

Does Your Spouse Influence Your DTC Viewing Experience?: FDA Wants to Peek Into Your...

This article is a review of FDA's proposed study titled 'Spousal Influence on Consumer Understanding of and Response to Direct-To-Consumer Prescription Drug Advertisements' (FDA-2014-N-1819)

A Formula for Patient-Centric mHealth Apps

This article summarizes the comments from a LinkedIn debate and #mHealthPharma TweetChat and condenses the learnings into one simple formula for creating quality pharma mHealth apps.

The Virtual Sales Rep – It’s Not About eDetailing!

A growing number of doctors prefer digital communications and the pharmaceutical industry is currently in the process of moving its sales force to a smaller structure that is more directly aligned with this new reality. One aspect of that change is the deployment of

Patient Activists Demand Higher Quality Mobile Health Apps: Pharma Must Listen, Respond, and Optimize!

Sooner or later Congress, perhaps urged on by patient advocates or some mhealth app adverse event, may investigate the mobile health app industry -- including the drug industry -- to see if further oversight, not just FDA regulations, is required. Before that happens and to ensure that mobile health apps developed by pharma are of the highest quality, the industry should differentiate itself from "wild west" developers by being pro-active in developing and abiding by a set of 'Guiding Principles for Mobile Health Apps.'

Pharma Marketing News Vol. 13, No. 4: April 2014

Welcome to Volume 13, Issue #4 (April 2014) of Pharma Marketing News.

Pharma Marketing News Vol. 13, No. 2: February 2014

Welcome to Volume 13, Issue #2 (February 2014) of Pharma Marketing News.

Correcting Independent 3rd-Party ‘Misinformation’ About Prescription Drugs

This article summarized the industry's response to the second FDA social media guidance document regarding correcting and/or responding to misinformation related to a firm's own FDA-approved products when that information is created or disseminated by independent third parties on the Internet or through social media.

Patient Storytelling Marketing: Creativity vs. Truth in Pharma Advertising

These days, patient storytelling is all the rage. More often than not, however, patient stories told by pharma marketers are not 'providing truth' in the sense that they are real patient stories.

Drug Industry Rips Into FDA Over Social Media Guidelines: Twitter & Google Adwords

This article summarizes some of the main points made by PhRMA, Washington Legal Foundation (WLF), BIO, Medical Information Working Group (MIWG), Patient, Consumer, and Public Health Coalition, and several pharmaceutical companies, regarding FDA's Draft Guidance on using Internet and social media platforms with character space limitations.
- Advertisement -